Cargando…
Hormonal Contraceptives and Risk of Breast Cancer: How to Explain it without Controversy
Autor principal: | Machado, Rogério Bonassi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Revinter Publicações Ltda
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316911/ https://www.ncbi.nlm.nih.gov/pubmed/29490411 http://dx.doi.org/10.1055/s-0038-1637742 |
Ejemplares similares
-
Controversies in the Use and Periodicity of Mammography as a Screening Method for Breast Cancer
por: Machado, Rogério Bonassi
Publicado: (2018) -
Progestogen-only oral contraceptives: Number 4 - April 2022
por: Machado, Rogério Bonassi, et al.
Publicado: (2022) -
Contraceptive counseling during the pandemic: practical guidelines: Number 7 - July 2021
por: Filho, Edson Santos Ferreira, et al.
Publicado: (2021) -
Controversies in contraception for women with epilepsy
por: Thomas, Sanjeev V.
Publicado: (2015) -
Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
por: Satish, Sanjana, et al.
Publicado: (2023)